The drug Trikafta has changed the lives of many Canadians living with cystic fibrosis. But in many other parts of the world, the drug is either not available — or if it is, it costs hundreds of thousands of dollars a year. That’s why Cheri Nel, who is based in Johannesburg, is suing American pharmaceutical company Vertex over its patent and price tag.
Mass graves discovered at Gaza hospitals
Push for global treaty on plastic pollution
Ontario scrapping sick notes for missed work
Why travel needs to change
What Canada can learn from Australia's gun buyback
Voyager 1 gets back in touch — from 24 billion km away
Learning about flow from a jazz player’s brain
More local politicians quitting over abuse
Is Canada ready for AI?
Could H5N1 become the next pandemic?
What dying people see in their dreams
What’s at stake in India’s election?
Lawyer alleges police perjury in Umar Zameer murder trial
What Sophie Grégoire Trudeau did next
The Current presents What On Earth: “Can Earth Day be badass again?”
What’s Canada doing about ‘forever chemicals’?
An ‘agonizing’ time on an enormous cruise ship
Cash prizes for (some) Olympic winners
U.S. pledges billions for Ukraine
India accused of plots to assassinate critics
Create your
podcast in
minutes
It is Free
Front Burner
Vinyl Cafe
Ideas
Someone Knows Something
Under the Influence with Terry O’Reilly